From The Editor-In-Chief
Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
Getting Help to Avoid Financial Distress | Cryoablation May Be a Treatment Option for Some Patients | Makers of E-Cigarettes Tout Role in Smoking Cessation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | Managing Opioid-Related Constipation | What’s Next
YOUR CANCER GUIDE
Patients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
When families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
Cancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
Advocacy in Action
Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
Go With Your Gut | The ABCs of CBD
Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
Experts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
Readers share snapshots of their lives today.
Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
Identifying patients whose cancers will have durable responses to checkpoint inhibitors can guide treatment.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
Bladder cancer is the sixth most prevalent cancer in the United States and has a high rate of recurrence.
Handle With Care
donate to the AACR